BERLIN (GERMANY) – The head of Germany’s vaccines regulator said a few groups of people residing in Germany could be given coronavirus vaccination early next year.
Klaus Cichutek, head of the Paul Ehrlich Institut, told the Funke group of newspapers that Phase I and Phase II trials’ data showed an immune response from some vaccines.
He said, “If data from Phase III trials shows the vaccines are effective and safe, the first vaccines could be approved at the beginning of the year, possibly with conditions attached.”
“Based on assurances from manufacturers, the first doses for people in Germany will be available at that time, in accordance with the priorities set by the Standing Committee on Vaccination,” he added. He was making a reference about the group that recommends the use of licensed vaccines in Germany.
German biotechnology firm CureVac has not yet dismissed a speedy approval process for its potential vaccine. It is expected to be available in the market by mid-2021.
(Photos syndicated via Reuters)
This story has been edited by BH staff and is published from a syndicated field.